Olema Pharmaceuticals, Inc.
OLMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$42 | -$44 | -$30 | -$34 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $5 | $4 | $6 |
| Change in WC | $4 | $11 | -$16 | $2 |
| Other Non-Cash | $3 | -$1 | -$2 | -$1 |
| Operating Cash Flow | -$35 | -$30 | -$44 | -$26 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$72 | -$33 | -$143 | -$189 |
| Inv. Sales/Matur. | $89 | $67 | $98 | $75 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $17 | $34 | -$45 | -$114 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $244 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$3 | $0 | $1 |
| Financing Cash Flow | $0 | -$3 | $0 | $244 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$17 | $2 | -$89 | $104 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $52 | $51 | $139 | $36 |
| End Cash | $35 | $52 | $51 | $139 |
| Free Cash Flow | -$35 | -$30 | -$44 | -$26 |